Trial intelligence / Profile preview

Lutropin Alfa in Women at Risk of Poor Response

NCT01112358Phase 2Completed

Sponsor
Merck KGaA
Start
Dec 2005
Primary completion
Jan 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of lutropin alfa in infertility, sponsored by Merck KGaA. Started Dec 2005; status: completed.

02

Drugs

lutropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01112358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01112358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call